Doximity Inc Class A DOCS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if DOCS is a good fit for your portfolio.
News
-
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DOCS
-
DOXIMITY SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Doximity, Inc. - DOCS
-
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Doximity
-
DEADLINE ALERT for VFS, PERI, ASTS, DOCS: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against QuidelOrtho, Perion, Doximity, and SpaceMobile and Encourages Investors to Contact the Firm
-
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit
-
Doximity Announces Fourth Quarter and Fiscal Year 2024 Financial Results
-
DOCS INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Doximity, Inc. Investors with Substantial Losses Have Opportunity to Lead Case
Trading Information
- Previous Close Price
- $23.74
- Day Range
- $26.21–29.00
- 52-Week Range
- $19.71–36.29
- Bid/Ask
- $28.06 / $28.15
- Market Cap
- $5.23 Bil
- Volume/Avg
- 10.0 Mil / 1.6 Mil
Key Statistics
- Price/Earnings (Normalized)
- 31.14
- Price/Sales
- 12.13
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 5.37%
Company Profile
Doximity Inc is a digital platform for U.S. medical professionals. Its cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Growth
- Total Number of Employees
- 977
- Website
- https://www.doximity.com
Comparables
Valuation
Metric
|
DOCS
|
CMAX
|
NORDH
|
---|---|---|---|
Price/Earnings (Normalized) | 31.14 | — | — |
Price/Book Value | 5.80 | 0.52 | 2.92 |
Price/Sales | 12.13 | 0.01 | 6.13 |
Price/Cash Flow | 27.64 | — | 225.83 |
Price/Earnings
DOCS
CMAX
NORDH
Financial Strength
Metric
|
DOCS
|
CMAX
|
NORDH
|
---|---|---|---|
Quick Ratio | 7.71 | 0.41 | 2.39 |
Current Ratio | 8.03 | 0.42 | 2.39 |
Interest Coverage | — | −11.57 | −1,270.38 |
Quick Ratio
DOCS
CMAX
NORDH
Profitability
Metric
|
DOCS
|
CMAX
|
NORDH
|
---|---|---|---|
Return on Assets (Normalized) | 17.35% | −18.59% | −10.46% |
Return on Equity (Normalized) | 20.20% | −47.72% | −11.87% |
Return on Invested Capital (Normalized) | 18.22% | −12.91% | −12.17% |
Return on Assets
DOCS
CMAX
NORDH
Health Information Services Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
GEHC
| GE HealthCare Technologies Inc Common Stock | — | Ggwtdy | $37.1 Bil | |
VEEV
| Veeva Systems Inc Class A | Mrtkmkpfst | Ygtgx | $34.0 Bil | |
SOLV
| Solventum Corp | — | Lwphnw | $10.8 Bil | |
PMCUF
| Pro Medicus Ltd | — | Qzzgwx | $8.4 Bil | |
MTHRF
| M3 Inc | — | Ykffg | $7.1 Bil | |
MTHRY
| M3 Inc ADR | — | Lcxjvh | $7.1 Bil | |
HQY
| HealthEquity Inc | — | Pjdfy | $6.9 Bil | |
RCM
| R1 RCM Inc | — | Jrvl | $5.2 Bil | |
TXG
| 10x Genomics Inc Ordinary Shares - Class A | — | Tjh | $3.0 Bil |